Commentary regarding clinical and immunological outcomes of high‐ and low‐dose rituximab treatments in patients with pemphigus: a randomized, comparative, observer‐blinded study
Publisher: John Wiley & Sons Inc
E-ISSN: 1529-8019|28|3|174-175
ISSN: 1396-0296
Source: DERMATOLOGIC THERAPY, Vol.28, Iss.3, 2015-05, pp. : 174-175
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.